Increased number of tumor-infiltrated tolerogenic DCs alternatively activated M2 macrophages and CD4+FoxP3-expressing T regulatory cells (Tregs) create immunosuppressive milieu in the breast cancer microenvironment which results in the inhibition of tumoricidal immune cells and leads to the uncontrolled tumor growth and progression [5]. The gene discussed is CD4; the disease is neoplasm.